Profile data is unavailable for this security.
About the company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
- Revenue in USD (TTM)9.45m
- Net income in USD-19.87m
- Incorporated1999
- Employees141.00
- LocationEvogene Ltd13 Gad Feinstein Street, Park RehovotREHOVOT 7638517IsraelISR
- Phone+972 89311900
- Fax+972 89466724
- Websitehttps://evogene.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Edesa Biotech Inc | 0.00 | -6.93m | 13.83m | 16.00 | -- | 4.83 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
Aprea Therapeutics Inc | 1.28m | -12.93m | 14.12m | 7.00 | -- | 0.5524 | -- | 11.07 | -3.03 | -3.03 | 0.2898 | 4.95 | 0.0435 | -- | -- | 182,241.40 | -44.09 | -68.66 | -50.11 | -77.19 | -- | -- | -1,013.41 | -42,112.84 | -- | -- | 0.00 | -- | -- | -- | 87.32 | -- | 90.61 | -- |
NKGen Biotech Inc | 0.00 | -88.25m | 14.21m | 63.00 | -- | -- | -- | -- | -3.74 | -3.74 | 0.00 | -2.71 | 0.00 | -- | -- | 0.00 | -480.25 | -- | -- | -- | -- | -- | -- | -- | -- | -0.4822 | -- | -- | -100.00 | -- | -210.06 | -- | -- | -- |
Galecto Inc | 0.00 | -25.43m | 14.58m | 13.00 | -- | 0.5372 | -- | -- | -23.45 | -23.45 | 0.00 | 21.74 | 0.00 | -- | -- | 0.00 | -59.06 | -48.46 | -75.34 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
Impact Biomedical Inc | 0.00 | -4.25m | 14.60m | 1.00 | -- | 0.6265 | -- | -- | -0.3694 | -0.3694 | 0.00 | 2.03 | 0.00 | -- | -- | 0.00 | -9.59 | -- | -15.04 | -- | -- | -- | -- | -- | -- | -5.12 | 0.3377 | -- | -100.00 | -- | 38.51 | -- | -- | -- |
Microbot Medical Inc | 0.00 | -10.44m | 14.87m | 22.00 | -- | 2.38 | -- | -- | -0.81 | -0.81 | 0.00 | 0.3793 | 0.00 | -- | -- | 0.00 | -113.94 | -53.28 | -133.34 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
Evogene Ltd | 9.45m | -19.87m | 14.97m | 141.00 | -- | 4.92 | -- | 1.58 | -3.94 | -3.94 | 1.88 | 0.6018 | 0.2004 | 3.37 | 34.11 | 67,014.19 | -44.59 | -39.79 | -87.01 | -52.52 | 81.42 | -117.65 | -222.51 | -1,310.66 | 4.24 | -- | 0.3597 | -- | 236.72 | 26.41 | 10.36 | -- | 15.98 | -- |
Matinas BioPharma Holdings Inc | 0.00 | -22.91m | 15.07m | 32.00 | -- | 0.7891 | -- | -- | -5.10 | -5.10 | 0.00 | 3.81 | 0.00 | -- | -- | 0.00 | -78.48 | -44.62 | -85.80 | -48.25 | -- | -- | -- | -2,344.60 | -- | -- | 0.001 | -- | -65.62 | 55.71 | -9.26 | -- | -16.46 | -- |
Inhibitor Therapeutics Inc | 0.00 | -3.02m | 15.49m | 3.00 | -- | 3.74 | -- | -- | -0.0175 | -0.0175 | 0.00 | 0.024 | 0.00 | -- | -- | 0.00 | -34.83 | 27.48 | -34.99 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
Lyra Therapeutics Inc | 1.82m | -101.39m | 15.54m | 87.00 | -- | 0.5016 | -- | 8.54 | -1.61 | -1.61 | 0.0294 | 0.4733 | 0.0165 | -- | -- | 20,681.82 | -92.07 | -58.01 | -108.51 | -68.69 | -- | -- | -5,570.88 | -6,235.31 | -- | -- | 0.00 | -- | 14.31 | 4.60 | -13.39 | -- | 95.14 | -- |
Imunon Inc | 0.00 | -18.08m | 15.55m | 33.00 | -- | 2.71 | -- | -- | -1.92 | -1.92 | 0.00 | 0.398 | 0.00 | -- | -- | 0.00 | -94.15 | -50.18 | -132.90 | -60.27 | -- | -- | -- | -5,725.88 | -- | -- | 0.00 | -- | -100.00 | -- | 45.64 | -- | 26.69 | -- |
Monopar Therapeutics Inc | 0.00 | -7.12m | 16.23m | 10.00 | -- | 2.66 | -- | -- | -2.31 | -2.31 | 0.00 | 1.73 | 0.00 | -- | -- | 0.00 | -81.33 | -54.07 | -102.31 | -60.60 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -- | -- |
Athira Pharma Inc | 0.00 | -113.45m | 16.34m | 65.00 | -- | 0.196 | -- | -- | -2.97 | -2.97 | 0.00 | 2.17 | 0.00 | -- | -- | 0.00 | -71.06 | -30.73 | -83.81 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
SilverArc Capital Management LLCas of 30 Jun 2024 | 307.97k | 6.09% |
KSM Mutual Funds Ltd.as of 31 Jul 2024 | 31.33k | 0.62% |
Morgan Stanley & Co. LLCas of 30 Jun 2024 | 21.80k | 0.43% |
Migdal Mutual Funds Ltd.as of 30 Jun 2024 | 15.08k | 0.30% |
BNP Paribas Financial Marketsas of 30 Jun 2024 | 10.04k | 0.20% |
P&S Verm�gensberatungs AG Performance & Sicherheitas of 28 Jun 2024 | 10.00k | 0.20% |
LPL Financial LLCas of 30 Jun 2024 | 6.73k | 0.13% |
UBS Financial Services, Inc.as of 30 Jun 2024 | 6.60k | 0.13% |
G1 Execution Services LLCas of 30 Jun 2024 | 6.14k | 0.12% |
Geode Capital Management LLCas of 30 Jun 2024 | 5.90k | 0.12% |